Current with changes from the 2024 Legislative Session
Section 18-506 - Statewide Steering Committee on Services for Adults with Sickle Cell Disease(a) In this section, "Steering Committee" means the Statewide Steering Committee on Sickle Cell Disease.(b) There is a Statewide Steering Committee on Sickle Cell Disease.(c) The Steering Committee shall include representatives from: (1) Local and national groups that advocate for individuals with sickle cell disease;(2) Interest and support groups for individuals with sickle cell disease;(3) Community and consumer groups;(4) Academic and private clinical settings with knowledge and experience caring for adults with sickle cell disease;(5) Area hospitals caring for individuals with sickle cell disease; and(6) Pediatric clinics that care for children with sickle cell disease.(d) The Steering Committee shall: (1) Establish institution and community partnerships;(2) Establish a statewide network of stakeholders who care for individuals with sickle cell disease;(3) Educate individuals with sickle cell disease, the public, and health care providers about the State options for care of sickle cell disease; and(4) Identify funding sources for implementing or supporting the actions, studies, policies, regulations, or laws recommended by the Steering Committee, including funding from: (i) State, federal, and local government sources; andAmended by 2022 Md. Laws, Ch. 280, Sec. 1, eff. 7/1/2022.Amended by 2022 Md. Laws, Ch. 279, Sec. 1, eff. 7/1/2022.Amended by 2019 Md. Laws, Ch. 452, Sec. 1, eff. 6/1/2019.